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Abstract. Domain knowledge may be used in a medical application to avoid
wrong decisions, e.g., decisions raising contraindications. The contribution of
this paper is twofold. First, it presents an approach for exploiting domain knowl-
edge in a case-based decision support system in the domain of oncology. This
approach is based on the so-called conservative adaptation that provides a solu-
tion necessarily consistent with the domain knowledge. Second, this paper de-
scribes an approach for the evolution of this domain knowledge when the expert
rejects a proposed solution as being inconsistent with his/her knowledge. This
inconsistency is characteristic of a difference between the domain knowledge of
the system and the expert knowledge; from an interactive analysis, a piece of
knowledge to be added to the domain knowledge is pointed out. This approach to
domain knowledge evolution is implemented in a prototype called FRAKAS.
1 Introduction
One of the key issues for the development of a case-based decision support system in
a medical domain is to make its user avoid wrong decisions, since they may have dis-
astrous consequences. Therefore, warnings can be used to assure the user is keeping
a critical eye on the proposed solution (i.e., this amounts to issues on ergonomics of
man-machine interfaces). This can also be done by associating explanations to the pro-
posed solution [1]. Finally, some wrong decisions may be avoided thanks to the domain
knowledge DK (also known as domain ontology). For example, if it is stated in DK that
a treatment is contraindicated for a class of patients and if the target patient belongs to
this class, then this treatment must not be recommended to the patient.
Hence, domain knowledge may be used to control the CBR inference and to make it
avoid some wrong decisions. This knowledge has to be managed, meaning that it must
be capitalized, exploited (by reasoning processes), shared, and that it must evolve. This
paper concentrates on the second and fourth issues of this management: the exploitation
and the evolution of domain knowledge for a CBR medical application.
Section 2 presents the KASIMIR project which aims at decision knowledge man-
agement in oncology. This research project motivates the exploitation and the evolution
of domain knowledge. Its exploitation is performed by CBR processes and this paper
concentrates on a novel approach to it, conservative adaptation, that is described in
section 3. This approach provides a solution (a recommendation) that is consistent with
DK but may be inconsistent with the expert knowledge, due to the gap between DK and
this knowledge. Such a failure can be analyzed interactively with the expert and leads
to a new (repaired) solution together with a new piece of knowledge that is added to DK.
This constitutes an evolution of the domain, as detailed in section 4. Section 5 discusses
application of this work to case-based medical recommendation. Section 6 concludes
this paper and highlights some future work.
2 The 3 stages of the KASIMIR project
Medical context. The KASIMIR project aims at decision knowledge management in
oncology in the framework of Lorraine, a region of France. In this region, decision
making in oncology is based on protocols and therapeutic decision meetings (TDMs).
A protocol is a document describing the standard way of decision making in a
particular medical domain. For example, the breast cancer treatment protocol (simply
called “the protocol” in the following of the paper) explains the standard treatment for
the patients suffering from breast cancer. The protocol can be seen as a set of rules
Pat −→ Ttt where Pat is the representation of a class of patients by conditions on
their features and Ttt is the treatment recommendation for these patients. Unfortu-
nately, it is not possible in practice to enumerate all the possible conditions that make a
treatment applicable and desirable: there are a lot of exceptions in the real world. This is
an instance of what John McCarthy calls the qualification problem [2]. In practice, the
straight application of the protocol only gives a satisfying therapeutic recommendation
in 60 to 70% of the medical cases, according to the experts involved in the KASIMIR
project and to their everyday medical practice.
The other cases –called out of the protocol cases in the following– are examined
during TDMs that gather experts in each of the specialties involved in breast cancer
treatment (chemotherapy, radiotherapy, surgery, etc.). It has been shown that during
TDMs, the protocol is frequently used to solve the out of protocol cases, but is not
straightforwardly applicated: it is adapted to the peculiar features of the out of protocol
cases [3].
A side-effect of the TDMs is that, through discussions between experts during these
problem-solving sessions, the knowledge of these experts evolves.
In summary, decision making in oncology is based on (1) application and on (2) adap-
tation of the protocol and may lead to (3) an evolution of the expert knowledge.
The KASIMIR project. The KASIMIR project is also based on this 3 stage structure.
The protocol is represented in a knowledge representation formalism (namely, the ex-
pressive description logic OWL DL for the last version of the KASIMIR system) and
protocol adaptation is performed by a deductive reasoning mechanism based on this
formalism.
Protocol adaptation is considered as being a CBR process. More precisely, each rule
Pat −→ Ttt is considered as a source case (srce, Sol(srce)) –srce is a source
problem and Sol(srce) is a solution of srce– and thus the protocol is the set of source
cases, i.e., the case base. A target problem tgt represents an out of the protocol pa-
tient and protocol adaptation consists in (a) selecting a protocol rule (Pat −→ Ttt) =
(srce, Sol(srce)) such that srce = Pat is judged to be similar to tgt and (b) modi-
fying Sol(srce) = Ttt to the context of the target problem. Thus, protocol adaptation
is a CBR process where (a) is the retrieval step of this process and (b) is its adaptation
step. The research on protocol adaptation is synthesized in [4] but the present paper de-
scribes another approach, based on the so-called conservative adaptation (cf. section 3).
It must be noticed that a feature of this approach to case adaptation is that it provides a
solution Sol(tgt) to tgt that is necessarily consistent with the domain knowledge DK.
The third stage of the KASIMIR project is the knowledge evolution. This paper
presents an approach based on an interactive failure analysis. More precisely, the failure
that is considered in this paper corresponds to an inconsistency of the solution Sol(tgt)
with the expert knowledge, which points out a difference between this knowledge and
DK. Therefore, an analysis of this failure leads to an evolution of DK that makes it closer
to the domain knowledge. This interactive domain knowledge evolution is described in
section 4.
3 Applying Conservative Adaptation to Medical
Recommendations
The principle of conservative adaptation is to keep as much as possible from the source
case while being consistent with the target problem and the domain knowledge. This
approach to adaptation can be formalized thanks to a revision operator ◦: given two
knowledge bases ψ and µ, ψ ◦ µ is a knowledge base that entails µ and keeps as
much as possible from ψ. The AGM theory of revision (called after the [5]’s author
initials) consists in a set of postulates that a revision operator has to verify. This theory
has been applied to propositional logic (see [6]), and this is in this formalism that the
conservative adaptation has been formalized in [7]. In the present paper, the general
ideas of this approach to adaptation and an example of a conservative adaptation of a
breast cancer treatment is proposed.
Preliminaries. Let V be a finite set of propositional variables and Vpb and Vsol be
two disjoint subsets of V . A problem pb (resp., a solution Sol(pb)) is defined as be-
ing a propositional formula on Vpb (resp., on Vsol). A case (pb, Sol(pb)) can thus be
represented by the formula pb ∧ Sol(pb). DK is a formula on V representing the do-
main knowledge. An interpretation I is a function from V to the pair {true, false}.
If a ∈ V , I(a) is also denoted by aI . I is extended on the set of formulas in the usual
way ((f ∧ g)I = true iff fI = true and gI = true, etc.). A model of a formula f
is an interpretation I such that fI = true. Mod(f) denotes the set of models of f . f is
satisfiable means that Mod(f) 6= ∅. f entails g (resp., f is equivalent to g), denoted by
f  g (resp., f ≡ g), if Mod(f) ⊆ Mod(g) (resp., Mod(f) = Mod(g)), for two formulas
f and g. Finally, g f h (resp., g ≡f h) means that g entails h (resp., g is equivalent to
h) under f : f ∧ g  h (resp., f ∧ g ≡ f ∧ h).
The postulates for a revision operator ◦ in propositional logic can be found in [6].
Here, besides the intuition presented above, only two of the six postulates are pointed
out:
(R1) ψ ◦ µ  µ (the revision operator has to retain all the knowledge of the new
knowledge base µ);
(R2) If ψ ∧ µ is satisfiable, then ψ ◦ µ ≡ ψ ∧ µ (if the new knowledge base does not
contradict the old one, then every piece of knowledge of the two bases has to be
kept).
The revision operator of Dalal [8], ◦D, can be defined as follows. Let dist be the
Hamming distance between interpretations: dist(I,J ) is the number of a ∈ V such
that aI 6= aJ . Given two sets of interpretations M1 and M2, and an interpretation J ,
dist(M1,J ) is the minimum of dist(I,J ) for I ∈ M1 and dist(M1,M2) is the
minimum of dist(M1,J ) for J ∈ M2. Now, for λ ≥ 0 and a formula ψ, let G
λ(ψ)
be a formula such that:
Mod(Gδ(ψ)) = {J | J : interpretation on V and dist(Mod(ψ),J ) ≤ δ}
(this defines Gλ up to the logical equivalence ≡). The formulas Gλ(ψ) realizes a gen-
eralization scale of ψ, in the sense that ψ ≡ G0(ψ)  Gλ(ψ)  Gε(ψ) for any λ and ε
such that 0 ≤ λ ≤ ε. Intuitively, the revision of ψ by µ according to the Dalal revision
operator consists in generalizing in a minimal way ψ (along this scale) to make it consis-
tent with µ. More precisely, if∆ is the minimal value such thatG∆(ψ)∧µ is consistent,
then ψ ◦D µ = G
∆(ψ) ∧ µ (such a ∆ exists; in fact: ∆ = dist(Mod(ψ), Mod(µ))).
Formalization of conservative adaptation. Let tgt be a problem and
srce ∧ Sol(srce) be a case. The adaptation of this case to solve tgt aims at giving
a solution Sol(tgt) of tgt. Given a revision operator ◦, the ◦-conservative adaptation
consists in computing
CA◦(DK, srce ∧ Sol(srce), tgt) = (DK ∧ srce ∧ Sol(srce)) ◦ (DK ∧ tgt)
The result of this computation is a formula f such that f ≡DK tgt ∧ Sol(tgt) which
gives a solution Sol(tgt) to tgt.
This definition formalizes the idea that conservative adaptation consists in keeping
as much as possible from ψ = DK∧ srce∧ Sol(srce), i.e., the source case interpreted
in the framework of the domain knowledge, while being consistent with µ = DK∧ tgt,
i.e., the target problem interpreted in the framework of DK.
Example. Let us consider the example of a patient who is a woman with positive
hormone receptors (HR+), who has already had a radical mastectomy with a lymph
node dissection (Patey-done: Patey is the name of this surgery act), with no involved
lymph nodes (N-), who has a liver disease (liver-disease) and some other characteristics
not detailed here (γ, that compiles pieces of information about her gender, her age, her
tumor size, etc.). This patient corresponds to the following problem:
tgt = HR+ ∧ Patey-done ∧ N- ∧ liver-disease ∧ γ
Now, let us consider the source case srce ∧ Sol(srce) such that
srce = HR+ ∧ Patey-done ∧ N- ∧ c
Sol(srce) = FEC ∧ tamoxifen
In other words, this case corresponds to the protocol rule “If the patient has positive
hormone receptors, has already had a Patey surgery, no involved lymph nodes, and
some other characteristics not detailed here (denoted by c), then a treatment com-
posed of a chemotherapy based on FEC and a hormone therapy based on tamoxifen
is recommended.” Tamoxifen is a hormone therapy drug and FEC is composed of three
chemotherapy drugs: fluorouracil, epirubicin, and cyclophosphamide.
Now, let us consider the following domain knowledge:
DK = γ⇒ c (1)
∧ liver-disease⇒¬tamoxifen (2)
∧ (tamoxifen ∨ anti-aromatases ∨ ovary-ablation)⇔ anti-oestrogen (3)
∧ FEC ⇔(fluorouracil ∧ epirubicin ∧ cyclophosphamide) (4)
(1) indicates that a patient having the characteristics represented by γ has the charac-
teristics represented by c. (2) indicates that tamoxifen is contraindicated for persons
having a liver disease. (3) indicates that tamoxifen, anti-aromatases, and ovary ablation
are anti-oestrogen treatments and that they are the only available anti-oestrogen treat-
ments (in the context of a given hospital). Finally, (4) indicates how a FEC treatment is
composed: it indicates that a FEC treatment is recommended iff fluorouracil, epirubicin,
and cyclophosphamide are recommended.
Since tgt corresponds to a specific situation of the general case srce
(tgt DK srce), the source case (srce, Sol(srce)) is selected by the retrieval pro-
cess. However, a straightforward application of this source case contradicts the target
problem, given the domain knowledge: DK ∧ srce ∧ Sol(srce) ∧ tgt is unsatisfiable
(since DK ∧ liver-disease ∧ tamoxifen is). The ◦D-conservative adaptation gives:
CA◦D(DK, srce ∧ Sol(srce), tgt)
≡DK tgt ∧ FEC ∧ (¬tamoxifen ∧ (anti-aromatases ∨ ovary-ablation))
︸ ︷︷ ︸
Sol(tgt)
Tamoxifen, since it is contraindicated for the target patient, is removed, but accord-
ing to the conservative adaptation principle, as much as possible from Sol(srce) is
kept. In particular, tamoxifen DK anti-oestrogen and anti-oestrogen is kept (tgt ∧
anti-oestrogen is consistent). Thus, anti-aromatases ∨ ovary-ablation is proposed, fol-
lowing (3): ¬tamoxifen∧ anti-oestrogen (3) anti-aromatases∨ ovary-ablation. There-
fore, the hormone therapy recommended for the target patient according to Sol(tgt),
is a cure of anti-aromatases or an ovary ablation.
Remark. Conservative adaptation may also be seen as an instanciation of the reuse
and revise steps of the Aamodt and Plaza’s cycle [9]: reuse is performed by a simple
copy and revise by a revision operator. It can be noticed that, to our knowledge, the
revise step of the CBR cycle has not been related to the AGM theory of revision: we
have found only two papers on CBR using revision techniques. The first one is [10],
where revision was not used for the purpose of the reasoning process itself, but for
the maintenance of the case base and of a rule base when there are some evolutions
in time. The second one is [11]1 where a conservative plan modification strategy is
defined and related to revision. It appears that this strategy may be more complex (from
an algorithmic viewpoint) compared to non-conservative plan modification strategy.
In our approach, CBR is not used as a heuristic to speed up a first principle reasoner.
Nevertheless, a more careful comparison with [11] has to be carried out.
4 Failure Analysis for Medical Knowledge Acquisition
FRAKAS (FailuRe Analysis for domain Knowledge AcquiSition) is a prototype devel-
oped to illustrate the principles of domain knowledge acquisition based on adaptation
failure analysis. In this prototype, the source case srce ∧ Sol(srce) is adapted by
performing a conservative adaptation to solve the target problem tgt. The proposed so-
lution is presented to the expert who analyzes it and detects possible failures, thanks to
a graphical interface. Currently, two kinds of failures are handled by FRAKAS: (1) the
adapted solution is inconsistent with the expert knowledge and (2) the solution is partial
and the expert must make it precise before applying it.
In this section, we describe how FRAKAS processes the example introduced above.
We focus on the first kind of failure, i.e., when the solution proposed by the system is
inconsistent with the expert knowledge. More details about FRAKAS and the two kinds
of failures can be found in [12].
Study of the example with FRAKAS. In this example, the source case
srce ∧ Sol(srce) introduced above is adapted to solve tgt. The conservative adapta-
tion produces a set of interpretations (FRAKAS uses propositional logic as knowledge
representation formalism). Each interpretation is a possible solution of tgt.
To present a solution to the expert, FRAKAS proceeds in two steps: firstly only the
variables interpreted in the same way by all the interpretations are shown and then, if
this first part of the solution is validated by the expert, all the available interpretations
are displayed. Figure 1(a) shows the result of the conservative adaptation performed
according to DK and the feedback of the expert in form of checked boxes. It can be
observed that the expert indicates an inconsistency between the proposed solution and
his/her knowledge: epirubicin is inconsistent with liver-disease. The system uses this
feedback to acquire a new piece of knowledge. In figure 1(b), the confirmation screen is
presented: the acquired piece of knowledge is expressed in propositional logic and the
expert can add a textual explanation before allowing the system to learn this knowledge.
Textual explanations may be used off-line to acquire more domain knowledge.
Thus, after this step, the domain knowledge DK has evolved into DK′:
DK′ = DK ∧ ¬(liver-disease ∧ epirubicin) ≡ DK ∧ (liver-disease⇒¬epirubicin)
1 Many thanks to the anonymous referee who has suggested this reference.
(a) Result of the first conservative adaptation and feedback of the expert in form of checked
boxes: the expert points out an inconsistency between the domain knowledge and his/her
knowledge.
(b) The expert provides an explanation in plain text.
Fig. 1. First solution presented to the expert and his/her feedback (a). Plain text explanation pro-
vided by the expert (b).
Fig. 2. Solution presented to the expert, who validates it.
Then, a new conservative adaptation is performed with DK′:
CA◦D(DK
′, srce ∧ Sol(srce), tgt)
≡DK′ tgt ∧
(
¬FEC ∧ ¬epirubicin ∧ fluorouracil ∧ cyclophosphamide
∧ anti-oestrogen ∧ ¬tamoxifen ∧ (anti-aromatases ∨ ovary-ablation)
)
Since they are both inconsistent with DK′∧tgt, the system does not keep epirubicin
and FEC in the new solution. As the expert validates the first part of the solution (com-
mon variables), the system displays the three possible interpretations (cf. figure 2).
Since each interpretation is correct, the expert validates the solution.
5 Discussion
In [13], some adaptation patterns for case-based decision support are presented, that
were elaborated during sessions of adaptation knowledge acquisition from experts in
oncology, on the basis of actual medical cases. These patterns are generally based on
the following features of a decision: its applicability, its positive consequences (i.e.,
its expected therapeutic benefits), and its negative consequences (i.e., its undesirable
effects). This section shows how some of the adaptations matching these patterns may
be modeled by a case-based decision process that provides a solution consistent with the
domain knowledge (such as a process with a conservative adaptation): they correspond
to some pieces of knowledge f either in DK or that can be acquired by failure analysis.
The fact that a treatment ttt is inapplicable for a class of patients pat can be
modeled by the piece of knowledge f = pat⇒¬ttt. Thus, if Sol(srce) DK ttt,
tgt DK pat, DK  f , and if Sol(tgt) is consistent with DK ∧ tgt, then Sol(tgt) 6DK
ttt. For example, an ovary ablation cannot be performed on a man (for obvious rea-
sons): f = man⇒¬ovary-ablation.
The fact that a treatment ttt is contraindicated for a class of patients pat means
that its negative consequences are too high. It can be modeled in the same way as
for inapplicable treatments: f = pat⇒¬ttt. Two examples of contraindications
have been presented in the two previous sections: they correspond to
f = liver-disease⇒¬tamoxifen and to f = liver-disease⇒¬epirubicin.
The fact that a treatment ttt is ineffective for a class of patients pat can be modeled
by f = (ttt∧pat)⇒ ineffective-treatment. The assumption “An ineffective treatment
must be avoided” can be modeled by the piece of knowledge g = ¬ineffective-treatment.
Thus, if Sol(srce) DK ttt, tgt DK pat, DK  f ∧ g, and if Sol(tgt)
is consistent with DK ∧ tgt, then Sol(tgt) 6DK ttt. For example,
tamoxifen is not effective for women with negative hormone receptors (¬HR+):
f = (tamoxifen ∧ ¬HR+)⇒ ineffective-treatment. Therefore, under the assumption
f ∧ g, if Sol(srce) is a therapeutic recommendation including tamoxifen, then the
recommendation Sol(tgt) does not include this drug.
6 Conclusion and Future Work
In this paper, one of the key roles of the domain knowledge DK of a case-based de-
cision support system is highlighted: it enables this system to avoid proposing some
wrong solutions (the ones that contradict DK). This is useful in particular for medical
applications for avoiding inapplicable, contraindicated, and useless treatment recom-
mendations. This requires an approach to case-based reasoning that provides solutions
that are consistent with DK. This is the case for a system using conservative adaptation,
an approach to adaptation based on a revision operator and that consists in keeping
as much as possible from the source case while being consistent with DK and the tar-
get problem (more details can be found in [7]). Unfortunately, due to the qualification
problem, there is a gap between DK and the expert knowledge. Thus, a solution consis-
tent with DK may be considered to be inconsistent with the expert. This failure can be
analyzed interactively and leads to a new piece of knowledge to be added to DK: this is
what the prototype FRAKAS does (see [12] for more details).
This paper is a contribution to formalization of CBR in health science, a trend pre-
sented in [14]. Indeed, it proposes a formalization of reasoning from medical cases with
the help of the domain knowledge. Furthermore, it is destinated to be integrated in the
KASIMIR system that is based on semantic Web technologies for representing cases
and domain knowledge [15]: the Web ontology language OWL is used as it is in the
Mémoire system [16].
The research about conservative adaptation and FRAKAS is still at its beginning and
there are several research directions. Some of them are presented in [7] for conservative
adaptation and in [12], for FRAKAS. Two other directions of research are more about
medical applications, though they may be extended to other domains.
In section 5, binary distinctions between treatment recommendations for a patient
are made: applicable/inapplicable, non contraindicated/contraindicated, and
useful/useless. In the real world, these distinctions are often gradual. For example, let us
consider an aged patient, with low mobility, living far from a radiotherapy center. This
situation makes the recommendation of daily radiotherapy sessions during 3 weeks dif-
ficult to apply but not strictly inapplicable. In such a situation, the recommendation
may be different from a binary choice (either this daily radiotherapy or no radiother-
apy): it may be a compromise (such as a radiotherapy with less frequent sessions). How
these gradual situations could be handled thanks to conservative adaptation is an open
research issue.
Another future work is to improve the modeling of these reasons to adapt (inappli-
cability, contraindication, uselessness). For example, the contraindication of a treatment
ttt for a class of patients pat has been modeled by pat⇒¬ttt. Now, consider the
contraindication of epirubicin for patients with a heart problem. One way to adapt a
FEC treatment is by removing epirubicin (as in section 4). Another way is to keep
epirubicin and to add a drug that prevents from the undesirable effects of epirubicin on
the heart. This solution is sometimes recommended by physicians but is not consistent
with f = heart-problem⇒¬epirubicin. Therefore, a more sophisticated modeling of
contraindications is required, and this may also be true for the modeling of treatment in-
applicability and treatment uselessness. This also raises the problem of the FRAKAS in-
terface: with the above example, the expert will probably check the boxes heart-problem
and epirubicin, that leads to the knowledge ¬(heart-problem ∧ epirubicin) which is
equivalent to f . In a further version of FRAKAS, a new interface based on the reasons
to adapt may be developed. One can imagine such an interface with a tab for each rea-
son to adapt. With the above example, the expert may choose the “contraindication tab”
and indicate that epirubicin is contraindicated because of heart-problem. This involves
two improvements with the current version: first, it associates explanations to pieces of
knowledge and second, it enables to use a sophisticated model of, e.g., contraindication.
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